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everal lines of evidence suggest that neurotrophins
(NTs) potentiate or cause neuronal injury under various
pathological conditions. Since NTs enhance survival
and differentiation of cultured neurons in serum or deﬁned
media containing antioxidants, we set out experiments to
delineate the patterns and underlying mechanisms of brain-
derived neurotrophic factor (BDNF)–induced neuronal injury
in mixed cortical cell cultures containing glia and neurons
in serum-free media without antioxidants, where the three
major routes of neuronal cell death, oxidative stress, excito-
toxicity, and apoptosis, have been extensively studied. Rat
cortical cell cultures, after prolonged exposure to NTs,
underwent widespread neuronal necrosis. BDNF-induced
S
 
neuronal necrosis was accompanied by reactive oxygen
species (ROS) production and was dependent on the macro-
molecular  synthesis. cDNA microarray analysis revealed
that BDNF increased the expression of cytochrome b
 
558
 
,
the plasma membrane-spanning subunit of NADPH oxidase.
The expression and activation of NADPH oxidase were
increased after exposure to BDNF. The selective inhibitors of
NADPH oxidase prevented BDNF-induced ROS production
and neuronal death without blocking antiapoptosis action
of BDNF. The present study suggests that BDNF-induced
expression and activation of NADPH oxidase cause oxidative
neuronal necrosis and that the neurotrophic effects of NTs
can be maximized under blockade of the pronecrotic action.
 
Introduction
 
Survival of central and peripheral neurons largely depends
on contact with neurotrophins (NTs)* that are released from
their target cells (Levi-Montalcini, 1987; Barde, 1994). The
neurotrophic effect of NTs is initiated through binding to
TrkA, TrkB, or TrkC, the high affinity NT receptors with
tyrosine kinase activity (Kaplan and Miller, 2000; Patapoutian
and Reichardt, 2001). The Trk tyrosine kinases activate the
small GTP-binding protein Ras, PI-3K, and PLC
 
 
 
, which play
an important role in survival of a variety of neurons, including
cerebellar granule, cortical, hippocampal, sympathetic, and
sensory neurons (Borasio et al., 1993; Stephens et al., 1994;
Yao and Cooper, 1995; Nobes et al., 1996; Nonomura et al.,
1996; Alcantara et al., 1997; Hetman et al., 1999; Atwal et
al., 2000). NTs enhance neuronal survival by interfering
with programmed cell death or apoptosis in the process of
normal development (Barde 1994; Deshmukh and Johnson,
1997). The neuroprotective effects of NTs have been observed
in the central neurons subjected to pathological insults. For
example, NTs ameliorate degeneration of basal forebrain
cholinergic neurons, retinal ganglion neurons, and spinal
sensory and motor neurons after axotomy in vivo (Hefti,
1986; Mey and Thanos, 1993; Morse et al., 1993; Yan et al.,
1993; Cohen et al., 1994; Friedman et al., 1995). NGF,
brain-derived neurotrophic factor (BDNF), and NTs-4/5
can reduce neuronal death after hypoxic-ischemic injury
(Shigeno et al., 1991; Beck et al., 1994; Chan et al., 1996).
BDNF protects dopaminergic neurons from 1-methyl-
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-dichlorodi-
hydrofluorescein; DCF, dichlorofluorescein; DIV, days in vitro; DPI,
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N
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D
 
-aspartate;
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Key words: BDNF; reactive oxygen species; necrosis; cycloheximide;
NADPH oxidase 
822 The Journal of Cell Biology 
 
|
 
 
 
Volume 159, Number 5, 2002
 
Figure 1.
 
Prolonged exposure to NTs produces neuronal cell necrosis in cortical cell cultures. 
 
(A) Mixed cortical cell cultures (DIV 12–15) 
were continuously exposed to 10, 30, and 100 ng/ml of NGF, BDNF, or NT-3 for the indicated points of time. Neuronal cell death was 
assessed by measurement of LDH efflux to the bathing medium, mean 
 
 
 
 SEM (
 
n
 
 
 
 
 
 16 culture wells per condition). *Significant difference 
from the relevant control (sham washed control) at P 
 
 
 
 0.05 using analysis of variance and Student-Neuman-Keuls test. (B) Brain sections 
were stained with hematoxylin-eosin at 2 d after intrastriatal injections of 5 
 
 
 
l of saline or 5 
 
 
 
g BDNF. Bright field photomicrogrphs showing 
a representative striatal area 1 mm lateral to the injection site of saline (a) or BDNF (b). Note the pyknotic neurons (arrows) in BDNF-treated  
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Table I. 
 
Genes expressed in rat cortical cell cultures treated with BDNF for 8 h
Entrez definition Fold change
Differentiation or proliferation
 
Rattus norvegicus
 
 dual specificity protein tyrosine phosphatase (rVH6) mRNA
 
 
 
1.23
 
Rattus norvegicus
 
 SC1 protein mRNA
 
 
 
1.27
 
Rattus norvegicus
 
 mRNA for CPG2 protein
 
 
 
10.46
 
Rattus norvegicus
 
 mRNA for urokinase-type plasminogen activator
 
 
 
2.38
 
Rattus norvegicus
 
 DCN mRNA for decorin
 
 
 
2.53
 
Signal transduction
 
Rat mRNA for 230-kD phosphatidylinositol 4-kinase, complete cds
 
 
 
1.71
 
Rattus norvegicus
 
 centaurin alpha mRNA, complete cds
 
 
 
4.32
 
Rattus norvegicus
 
 nicotinic acetylcholine receptor alpha4-2 mRNA
 
 
 
2.45
 
Rattus norvegicus
 
 class A calcium channel variant riA-I (BCCA1) mRNA
 
 
 
7.23
 
Metabolism or synthesis
 
Rattus norvegicus
 
 mRNA for ribosomal protein S24
 
 
 
2.19
Rat lysozyme gene exons 1–4, complete cds
 
 
 
3.31
Rat PYBP1 mRNA for pyrimidine binding protein 1
 
 
 
1.85
Rat mRNA for brain acyl-CoA synthetase 2
 
 
 
0.16
Rat mRNA for ribosomal protein L1
 
 
 
0.99
 
Rattus norvegicus
 
 palmitoyl protein thioesterase mRNA
 
 
 
0.89
Rat mRNA for long-chain acyl-CoA synthetase (EC 6.2.1.3)
 
 
 
0.48
Rat vacuolar protein sorting homolog r-vps33a mRNA, complete cds
 
 
 
0.13
Rat Rieske iron-sulfur protein mRNA, complete cds
 
 
 
0.46
 
Rattus norvegicus
 
s ribosomal protein L21 mRNA, complete cds
 
 
 
0.21
Rat ARSB mRNA for arylsulfatase B, partial cds
 
 
 
0.49
 
Endocytosis
 
Rattus norvegicus
 
 clathrin light chain (LCA1) mRNA
 
 
 
10.85
 
Rattus norvegicus
 
 vesicular transport protein rvps45 mRNA
 
 
 
0.53
 
Other function
 
Rattus norvegicus
 
 alpha 4 phosphoprotein mRNA
 
 
 
2.76
 
Rattus norvegicus
 
 cytochrome b558 alpha-subunit mRNA
 
 
 
7.71
 
Rattus norvegicus
 
 serine proteinase rPC7 precursor (Pcsk7) mRNA, complete cds
 
 
 
3.72
 
Rattus norvegicus
 
 (Wistar) CaBP1 mRNA
 
 
 
0.08
Rat CoxVa mRNA for mitochondrial cytochrome c oxidase subunit Va
 
 
 
0.01
 
Rattus norvegicus
 
 CD59 protein precursor, mRNA, complete cds
 
 
 
0.12
Rat cytochrome P-450 isozyme 5 (P450 IVB2) mRNA, complete cds
 
 
 
0.14
 
Rattus norvegicus
 
 mRNA for dual specificity Yak1-related kinase (Dyrk)
 
 
 
0.32
 
striatal area. Striatal lesion was analyzed by measuring the injured areas (c), mean 
 
 
 
 SEM (
 
n
 
 
 
 
 
 5 rats per each condition). *Significant difference 
from the relevant control (saline injected) at P
 
 
 
 
 
 0.05 using Independent-Samples 
 
t
 
 test. (C) Phase–contrast (top) and electron (bottom) 
photomicrographs of cortical neurons 32 h after a sham wash (a and c) or continuous exposure to 100 ng/ml BDNF (b and d). Note that 
BDNF treatment induces swelling of neuronal cell body (arrow), scattering condensation of nuclear chromatin (arrowhead), and fenestration 
of plasma membrane characteristic of necrosis. (D) Patterns of BDNF-induced neuronal death were analyzed at 32 h after exposure of cortical 
cell cultures to 100 ng/ml BDNF. Approximately 200 neurons from control and BDNF-treated cultures were randomly selected and observed 
under transmission electron microscope. Degenerating neurons were defined as normal, necrosis (see above), or apoptosis (shrinkage of 
cytoplasm and nuclear membrane rupture with intact plasma membrane). (E) Cortical cell cultures (DIV 12–15) were continuously exposed to 
100 ng/ml BDNF, alone or with 100 
 
 
 
g/ml anti-BDNF blocking antibody, 150 nM K252a, 10 
 
 
 
M MK-801, 50 
 
 
 
M CNQX, 10 
 
 
 
M MK 801 
plus 50 
 
 
 
M CNQX, 100 
 
 
 
M trolox, or 1 
 
 
 
g/ml cycloheximide (CHX). Neuronal death was analyzed 36 h later by measurement of LDH efflux 
into the bathing medium, mean 
 
 
 
 SEM (
 
n
 
 
 
 
 
 16 culture wells per condition). *Significant difference from the relevant control (BDNF alone) at 
P 
 
 
 
 0.05 using analysis of variance and Student-Neuman-Keuls test.
 
4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxy dopamine
(Spina et al., 1992; Frim et al., 1994).The findings above
suggest therapeutic potential of NTs for hypoxic-ischemia
and various neurodegenerative diseases. However, the beneficial
effects of NTs should be compromised with a notion that
NTs can exacerbate certain forms of neuronal injury.
BDNF, NT-3, or NT-4/5 renders neurons highly vulnerable
to deprivation of oxygen and glucose, possibly by enhancing
 
Ca
 
2
 
 
 
 influx and nitric oxide production through 
 
N
 
-methyl-
 
D
 
-aspartate (NMDA) glutamate receptors (Fernandez-Sanchez
and Novelli, 1993; Koh et al., 1995; Samdani et al., 1997).
NTs potentiate neuronal death by reactive oxygen species
(ROS) or nitric oxide, which was blocked by cycloheximide
(Gwag et al., 1995; Park et al., 1998; Kim et al., 1999; Ishikawa
et al., 2000). These studies imply that NTs can potentiate
necrotic components of neuronal death. In addition, NTs 
824 The Journal of Cell Biology 
 
|
 
 
 
Volume 159, Number 5, 2002
 
can directly induce death of neurons, oligodendrocytes,
Schwann cells, and tumor cells (Casaccia-Bonnefil et al.,
1996; Muragaki et al., 1997; Sedel et al., 1999; Soilu-Han-
ninen et al., 1999; Giehl et al., 2001).
Recently, we have found that cortical cell cultures exposed
to NTs can undergo neuronal death. The present study was
performed to determine the morphological patterns, apopto-
sis versus necrosis, of neuronal death induced by NTs. In ad-
dition, we set out experiments to examine the possibility
that necrotic pathways (e.g., excitotoxicity and oxidative
stress) and putative target genes would mediate the neuro-
toxic action of NTs.
 
Results
 
BDNF induces neuronal cell necrosis
 
Administration of NTs did not produce neuronal injury in
cortical cell cultures within 1 d when NTs can prevent neu-
ronal apoptosis and potentiate neuronal death after depriva-
tion of oxygen and glucose (Koh et al., 1995). However,
wide spread neuronal death occurred in cortical cell cultures
continuously exposed to various concentrations (10, 30, or
100 ng/ml) of BDNF or NT-3 for 36–48 h (Fig. 1 A). Near
complete neuronal death was observed within 48 h after ex-
posure to BDNF or NT-3. Neuronal death was not in-
duced by exposure to NGF, since cortical neurons express
TrkB and TrkC but not TrkA (Knüsel et al., 1992; Wid-
mer et al., 1992). The neurotoxic effects of NTs were ob-
served in striatal areas 2 d after the intrastriatal injections of
BDNF in adult rat brain (Fig. 1 B). The cell body swelling
preceded the latent neuronal death as shown in the process
of necrotic neuronal death after insults to excitotoxins or
 
prooxidants (Gwag et al., 1997; Ryu et al., 1999). The ul-
trastructural analysis of degenerating neurons in BDNF-
treated cortical cultures reveals swelling of cytoplasmic or-
ganelles, earlier collapse of plasma membrane than nuclear
membrane, and scattering condensation of nuclear chroma-
tin (Fig. 1, C and D).
BDNF-induced neuronal necrosis was completely blocked
by inclusion of K252a, an inhibitor of the Trk receptor ty-
rosine kinases, and 100 
 
 
 
g/ml anti-BDNF blocking anti-
body, suggesting that Trk mediates the neurotoxic actions
of NTs (Fig. 1 E). Since excess activation of iono-
tropic glutamate receptors sensitive to NMDA, 
 
 
 
-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and
kainite and oxidative stress cause neuronal death exclusively
through necrosis (Gwag et al., 1997; Ryu et al., 1999), ex-
periments were performed to examine if glutamate receptor
antagonists or antioxidants would block BDNF-induced
neuronal cell necrosis. Neither the NMDA receptor antago-
nist MK-801 nor the AMPA/kainite receptor antagonist
CNQX reduced BDNF-induced neuronal necrosis, suggest-
ing that excitotoxicity does not mediate BDNF neurotoxic-
ity (Fig. 1 E). However, concurrent administration of trolox,
a lipophilic analogue of vitamin E, completely blocked
BDNF neurotoxicity. Interestingly, BDNF-induced neu-
ronal cell necrosis was also blocked by addition of cyclohex-
imide, a protein synthesis inhibitor. Thus, BDNF appears to
produce free radical–mediated neuronal cell necrosis in a
protein synthesis-dependent manner.
 
BDNF produces ROS in cortical neurons
 
Additional experiments were performed to examine whether
BDNF would produce ROS in cortical cell cultures. The
Figure 2. BDNF produces ROS in 
cortical neurons: involvement of protein 
synthesis. (A) Cortical cell cultures 
(DIV 12–15) were exposed to a sham 
wash ( ) or 100 ng/ml BDNF ( ). Levels 
of ROS in neurons were analyzed at 
indicated times by measuring fluorescence 
intensity of oxidized DCDHF-DA (DCF), 
mean   SEM (n   30–35 neurons 
randomly chosen from four culture wells 
per condition). *Significant difference 
from the relevant control (sham wash) 
at P   0.05 using analysis of variance 
and Student-Neuman-Keuls test. 
(B and C) Fluorescence photomicrographs 
(B) and quantitation (C) of DCF in cortical 
neurons after 32 h exposure of cortical 
cell cultures (DIV 12–15) to a sham 
wash (CTRL) or 100 ng/ml BDNF, alone 
(BDNF) or in the presence of 1  g/ml 
cycloheximide (CHX) or 100  M trolox 
(TROLOX). *Significant difference from 
the control (CTRL); 
#significant difference 
from the BDNF control (BDNF alone) at 
P   0.05 using analysis of variance and 
Student-Neuman-Keuls test. 
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overall level of ROS was determined by analyzing oxidation
of 2
 
 
 
,7
 
 -dichlorodihydrofluorescein (DCDHF) to dichloro-
fluorescein (DCF). The fluorescent intensity of DCF was in-
creased in cortical neurons exposed to BDNF for 16 h (Fig.
2 A). The intraneuronal levels of ROS ([ROS]i) were further
increased over 24–32 h. Treatment with BDNF did not in-
crease levels of ROS in astrocytes that grew as a monolayer
underneath neurons (unpublished data). The BDNF-induced
production of [ROS]i was prevented by concurrent addition
of cycloheximide and trolox (Fig. 2 B, and C). Thus, BDNF
likely produces ROS presumably through synthesis of pro-
oxidant proteins.
BDNF increases expression of NADPH oxidase
We used cDNA microarray assay to screen target genes for the
prooxidant action of BDNF in cortical cell cultures. The mi-
croarray analysis revealed that various genes were regulated in
cortical cell cultures exposed to BDNF for 8 h (Table I). The
target genes of BDNF mostly play a role in differentiation, en-
docytosis, metabolism, and signal transduction that likely re-
flect neurotrophic actions of NTs. Among the BDNF-sensi-
tive genes, cytochrome b558 was chosen as a candidate gene for
the neurotoxic actions of the NT, since it constitutes p22-
phox and gp91-phox subunits of NADPH oxidase, a prooxi-
dant enzyme generating superoxide from oxygen. RT-PCR
analysis showed an increase in mRNA levels of p22-phox and
gp91-phox within 2 h after treatment with BDNF (Fig. 3).
Levels of both mRNAs were maximally increased 4 h later,
which lasted over the next 12 h. The mRNA levels of p47-
phox subunit were also increased gradually from 30 min after
administration of BDNF. Western blot experiments were per-
formed to analyze protein levels of NADPH oxidase subunits
using available antibodies for gp91-phox, p47-phox, and p67-
phox. Expression of these subunits was increased over 16–32 h
in cortical cell cultures exposed to BDNF (Fig. 4 A). Immu-
Figure 3. BDNF increases mRNA levels of NADPH oxidase 
subunits in cortical cultures. RT-PCR analysis of NADPH oxidase 
subunits (p22-phox, gp91-phox, and p47-phox) and GAPDH mRNA 
expression in cortical cell cultures (DIV 12) exposed to 100 ng/ml 
BDNF for indicated times. The mRNA level of each NADPH oxidase 
subunit was normalized to the relevant control value (t   0). Similar 
results were observed from three separate experiments.
Figure 4. BDNF increases expression of NADPH oxidase subunits 
in cortical neurons. (A) Western blot analysis of NADPH oxidase 
subunits (gp91-phox, p47-phox, and p67-phox) and actin in cortical 
cell cultures after exposure to 100 ng/ml BDNF for indicated times. 
Similar results were obtained from three separate experiments. 
(B) Fluorescence photomicrograph of cortical cell cultures immuno-
labeled with NeuN (right; anti–mouse immunoglobulin G conjugated 
with Texas red) and anti-p47-phox (left; anti–goat immunoglobulin G 
conjugated with FITC) after exposure to a sham wash (top) and 100 
ng/ml BDNF (bottom) for 32 h. (C) Same as B except that cultures 
were immunolabeled with anti–p67-phox antibody (anti–goat 
immunoglobulin G conjugated with FITC) instead of anti–p47-phox. 
Note that levels of p47-phox and p67-phox were increased selectively 
in neurons after exposure of mixed cortical cell cultures to BDNF.826 The Journal of Cell Biology | Volume 159, Number 5, 2002
nocytochemistry was performed to identify which types of
cells express NADPH oxidase in cortical cell cultures contain-
ing neurons and glia. Immunoreactivity to p47-phox or p67-
phox antibody was slightly observed in cortical neurons but
not in astrocytes after a sham operation. Signals of p47-phox
and p67-phox were increased exclusively in neurons 32 h after
exposure of cortical cell cultures to BDNF (Fig. 4, B and C).
BDNF produces ROS through activation 
of NADPH oxidase
Activation of NADPH oxidase involves translocation of the
cytosolic p47-phox and p67-phox subunits into the plasma
membrane (Clark et al., 1989). The levels of p47-phox and
p67-phox were reduced in the cytosolic fraction and increased
in the membrane fraction from cortical cell cultures exposed to
BDNF for 16–32 h (Fig. 5 A), suggesting that treatment with
BDNF results in activation of NADPH oxidase. This was fur-
ther supported by increased production of superoxide up to
three- to fourfold in cortical cell cultures treated with BDNF
for 16–32 h as determined by the reduction of cytochrome c
(Fig. 5 B). Treatment with BDNF resulted in the increased
oxidation of hydroethydine and 2 , 7 -dichlorodihydrofluores-
cein to ethidium and dichlorofluorescein, respectively, exclu-
sively in neurons (Fig. 5 C). We analyzed the inhibitory effects
of diphenylene iodonium (DPI), a selective inhibitor of fla-
voprotein-dependent enzymes such as cytochrome b558, the
plasma membrane–spanning subunit of NADPH oxidase
(O’Donnell et al., 1993), against BDNF-induced superoxide
production. DPI completely blocked BDNF-induced super-
oxide production (Fig. 5, B and C). Thus, BDNF produces
oxidative stress in cortical neurons through NADPH oxidase-
mediated production of superoxide.
Activation of NADPH oxidase mediates 
BDNF neurotoxicity
We examined if activation of NADPH oxidase would con-
tribute to BDNF-induced neuronal death. Coadministra-
tion of NADPH oxidase inhibitors, 3–10 nM DPI or 10–
30  M 4-(2-aminoethyl)-benzensulfonyl fluoride (AEBSF),
significantly reduced swelling of neuronal cell body and
Figure 5. Translocation and activation of NADPH oxidase by BDNF. (A) Western blot analysis of the cytosolic fraction (C) and the membrane 
fraction (M) using anti–p47-phox and anti–p67-phox antibodies that were obtained from cortical cell cultures (DIV 12) after exposure to 
100 ng/ml BDNF for the indicated times. (B) Superoxide production was analyzed by measuring reduction of cytochrome c in cortical 
cultures exposed to a sham wash ( ) or 100 ng/ml BDNF with (gray colored circles) or without 3 nM DPI ( ) for indicated times, mean   SEM 
(n   12 culture wells per condition). *Significant difference from the sham control at P   0.05 using analysis of variance and Student-Neuman-
Keuls test. (C) Fluorescence photomicrograph of the oxidized hydroethydine (HEt, top) and DCF (bottom) in cortical neurons after exposure to 
a sham operation (CTRL), 100 ng/ml BDNF (BDNF), or 100 ng/ml BDNF plus 3 nM DPI (DPI) for 32 h. BDNF induces neuronal death through NADPH oxidase | Kim et al. 827
neuronal death 36 h after exposure of cortical cell cultures
to BDNF (Fig. 6). However, neither DPI nor AEBSF pre-
vented oxidative neuronal death evolving 24 h after expo-
sure of cortical cell cultures to 30  M Fe
2  (Fig. 6), which
was shown to produce hydroxyl radical through Fenton re-
action and neuronal cell necrosis in cortical cell cultures
(Ryu et al., 1999).
Finally, the putative role of NADPH oxidase was studied
regarding the antiapoptosis action of NTs. As reported pre-
viously (Koh et al., 1995), administration of BDNF pre-
vented apoptosis of cortical neurons deprived of serum for
24 h (Fig. 7). Neither DPI nor trolox alone reduced serum
deprivation-induced neuronal apoptosis. The antiapoptotic
action of BDNF was insensitive to inclusion of DPI or
trolox. Interestingly, the protective effects of BDNF disap-
peared within 48 h after serum deprivation. The delayed
neuronal death evolving in the presence of BDNF was ac-
companied by the marked swelling of cell bodies (unpub-
lished data) and attenuated by concurrent addition of DPI
or trolox (Fig. 7). The results suggest that expression and ac-
tivation of NADPH oxidase mediate the pronecrosis, but
not antiapoptosis, action of BDNF.
Discussion
We report that prolonged exposure to BDNF produces neu-
ronal cell necrosis in cortical cell cultures. Oxidative stress
and protein synthesis are required for BDNF neurotoxic-
ity. DNA microarray revealed transcriptional activation of
NADPH oxidase in BDNF-treated cortical cell cultures. In-
creased expression and activation of NADPH oxidase medi-
ate oxidative stress and neuronal death by BDNF.
Apoptosis and necrosis comprise two major patterns of
neuronal death occurring under physiological and patholog-
ical conditions. Apoptosis or shrinkage necrosis is character-
ized by early collapse of nuclear membrane and aggregated
condensation of nuclear chromatin evident under electron
microscope (Kerr, 1972). Necrosis denotes swelling necrosis
that is accompanied by early collapse of plasma membrane
and scattering condensation of nuclear chromatin (Wyllie et
al., 1980). According to the original criteria above, pro-
longed exposure to BDNF produced swelling necrosis in
cortical cell cultures. This supports a hypothesis that NTs
can act as pronecrotic factors while they promote neuronal
survival by preventing apoptosis (Gwag et al., 1995; Koh et
al., 1995). The Trk receptors appear to mediate the prone-
crotic effects of BDNF in cortical cell cultures that express
Trk B and Trk C but not the p75 NT receptor (p75NTR)
(Springer et al., 1990; Koh et al., 1995).
Excitotoxicity and oxidative stress have been recognized as
routes to neuronal cell necrosis in the nervous system. Excess
activation of NMDA, AMPA, or kainate receptors cause in-
flux of Ca
2 , Na
 , Cl
  and H2O that results in rapid swell-
ing of cell body, collapse of plasma membrane, and scatter-
ing condensation of nuclear chromatin (Hajos et al., 1986;
Choi, 1987; Dessi et al., 1993; Gwag et al., 1997). The sim-
ilar morphological patterns were observed in cortical neu-
rons exposed to prooxidants such as Fe
2  or Zn
2  (Gwag et
al., 1995; Park et al., 1998; Kim et al., 1999). Although
none of the ionotropic glutamate receptor antagonists pre-
vented BDNF-induced neuronal cell necrosis, the mem-
brane-permeable form of vitamin E completely blocked the
BDNF neurotoxicity. This implies that oxidative stress me-
diates the pronecrotic action of BDNF. In support of this,
treatment with BDNF produced ROS before swelling of
neuronal cell body.
It has been well documented that administration of NTs
increases neuronal survival and differentiation in vitro. It is
of notice that the neurotrophic effects of NTs have been ex-
amined primarily in defined media containing putrescin and
selenium as antioxidants (Alderson et al., 1990; Friedman et
al., 1993; Cohen et al., 1994). Thus, oxidative stress and
Figure 6. Activation of NADPH oxidase mediates BDNF-induced 
neuronal death. Cortical cell cultures (DIV 12–15) were exposed to 
100 ng/ml BDNF or 30  M Fe
2 , alone or in the presence of 3 nM 
DPI or 10  M AEBSF. Neuronal death was analyzed 36 h later by 
measurement of LDH efflux into the bathing medium, mean   SEM 
(n   16 culture wells per condition). *Significant difference from the 
relevant control (BDNF or Fe
2  alone) at P   0.05 by Student-
Neuman-Keuls test.
Figure 7. DPI or trolox enhances the neuroprotective effect of 
BDNF against serum deprivation. Neuron-rich cortical cell cultures 
(DIV 7) were deprived of serum, alone (serum deprivation) or in the 
presence of 100 ng/ml BDNF, 100 ng/ml BDNF plus 3 nM DPI, 
3 nM DPI, 100 ng/ml BDNF plus 100  M trolox, or 100  M trolox. 
Neuronal death was assessed 24 and 48 h later by counting viable 
neurons, mean   SEM (n   16 fields randomly chosen from four 
culture wells per condition). *Significant difference from the relevant 
control (serum deprivation alone) at P   0.05 using analysis of 
variance and Student-Neuman-Keuls test.828 The Journal of Cell Biology | Volume 159, Number 5, 2002
neuronal death by prolonged exposure to NTs appear to be
masked, exclusively revealing roles of NTs as survival and
differentiation factors. We have studied effects of NTs in
mixed cortical cultures of neurons and glia in culture media
without serum or antioxidants. Since neurons growing on
astrocytes can survive over several days in the absence of se-
rum or antioxidants, this culture condition has been widely
used to study mechanisms of excitotoxicity, oxidative stress,
and apoptosis. Under this culture condition, prolonged ex-
posure to NTs induced degeneration of cortical neurons that
were not observed in the presence of serum or antioxidants
(unpublished data). This suggests that neurontrophins act as
neurotrophic or neurotoxic factors depending on the pres-
ence of antioxidants.
Evidence is being accumulated that NTs potentiate neu-
ronal death after deprivation of oxygen and glucose or ad-
ministration of NMDA, free radical-inducing agents (Fe
2 
or buthionine sulfoximine),   amyloid, or nitric oxide in
vitro (Yankner et al., 1990; Gwag et al., 1995; Koh et al.,
1995; Ishikawa et al., 2000). The potentiation effects of
NTs have been reported in adult rat brain subjected to ad-
ministration of Fe
2  or cerebral ischemia (Won et al., 2000;
Bates et al., 2002). The present findings that NTs directly
cause oxidative stress likely underlie the potentiation effects
of NTs on some neuronal injuries.
Since concurrent treatment with cycloheximide inhibited
ROS production and neuronal death after exposure to
BDNF, we reasoned that expression of ROS-regulating en-
zymes would be altered in cortical neurons exposed to
BDNF. We first examined mRNA expression of antioxidant
enzymes such as manganese-superoxide dismutase and glu-
tathione peroxidase. RT-PCR analysis showed that mRNA
levels of these enzymes were increased up to two- to three-
fold 24 h after exposure of cortical cell cultures to BDNF
(Kim and Gwag, unpublished data). The late expression of
the antioxidant enzymes appears to represent adaptive re-
sponses to oxidative stress that is evolved within 16 h after
administration of BDNF. We then performed DNA mi-
croarray analysis to search for candidate molecules involved
in the prooxidant effects of BDNF and found that mRNA
levels of the p22-phox and gp91-phox NADPH oxidase sub-
units were increased within 8 h in cortical cell cultures ex-
posed to BDNF or NT-3 and NT-4/5.
NADPH oxidase was first discovered in phagocytes as a
superoxide-producing enzyme via one-electron reduction
of oxygen (Patriarca et al., 1971; Prough and Masters,
1973). NADPH oxidase consists of cytochrome b558, a
membrane heterodimer of gp91-phox and p22-phox, and
three cytosolic subunits, p40-phox, p47-phox, and p67-
phox (Parkos et al., 1987; Lomax et al., 1989; Okamura et
al., 1990). Activation of NADPH oxidase is initiated by
membrane translocation of p47-phox and p67-phox to in-
teract with cytochrome b558 (Clark et al., 1989; Heyworth
et al., 1991). Treatment with BDNF increased mRNA
(p22-phox, p47-phox, gp91-phox) and protein (p47-phox,
p67-phox, gp91-phox) levels of NADPH oxidase subunits
selectively in cortical neurons. Increased expression of sub-
units was followed by membrane translocation of p47-phox
and p67-phox and subsequent production of superoxide
presumably in the cytosol.
The weak oxidant superoxide can be converted to more
reactive oxidants including hydrogen peroxide, hydroxyl
radical, and other ROS primarily in mitochondria (Bannis-
ter et al., 1982; Miller and Britigan, 1995). BDNF-treated
cortical neurons revealed mitochondrial ROS production
within 16–24 h as determined by Mitotracker red CM-
H2Xros (unpublished data). The mitochondrial ROS pro-
duction and the overall oxidative stress by BDNF were re-
duced in the presence of the selective inhibitors of NADPH
oxidase. This implies that BDNF-induced superoxide results
in the secondary ROS production through mitochondria
and the delayed neuronal death.
Although activation of NADPH oxidase is required for the
oxidative neuronal necrosis by BDNF, it does not mediate the
antiapoptosis action of the NT. Surprisingly, the slowly evolv-
ing oxidative stress overrides the neuroprotective effect of
BDNF against serum deprivation-induced apoptosis. Thus,
the neurotrophic effect of BDNF is enhanced with blockade
of oxidative stress by NADPH inhibitors or antioxidants.
Several lines of evidence suggest that NADPH oxidase
participates in the process of neuronal injury under patho-
logical conditions. The infarct size after transient middle ce-
rebral artery occlusion was significantly reduced in mu-
tant mice with defect in NADPH oxidase (Walder et al.,
1997). Membrane translocation of p47-phox and p67-phox
was observed in Alzheimer’s disease brain (Shimohama et
al., 2000). Although mechanisms underlying activation of
NADPH oxidase remain to be delineated, Zn
2  can mediate
activation of NADPH oxidase in neurons and astrocytes.
Zn
2  is released from the presynaptic terminal of glu-
tamatergic neurons in an activity-dependent manner and en-
ters into adjacent neurons primarily through voltage-gated
Ca
2  channels and Ca
2 -permeable glutamate receptors
(Choi and Koh, 1998). Accumulation of Zn
2  causes ROS-
mediated neuronal necrosis in part through protein kinase
C–dependent activation of NADPH oxidase (Kim et al.,
1999; Noh and Koh, 2000). Fibrillary forms of   amyloid
activate NADPH oxidase in microglial cells (Bianca et al.,
1999), which can contribute to ROS production and degen-
eration of adjacent neurons. In addition to the endogenous
neurotoxins Zn
2  and   amyloid, NTs transcriptionally and
translationally activate NADPH oxidase in neurons and can
act as another neurotoxic substance in the nervous system.
We report for the first time that NTs can act as a prooxi-
dant through activation of NADPH oxidase and cause neu-
ronal cell necrosis through production of ROS. Although
NTs reveal neurotrophic activity by preventing apoptosis
and promoting regeneration (Levi-Montalcini, 1987; Barde,
1994; Deshmukh and Johnson, 1997), the current findings
suggest that the neurotrophic action of NTs should be ex-
ploited with blockade of the pronecrotic effects.
Materials and methods
Primary cortical cell culture
Rat cortical cell cultures were prepared from the 17-d-old fetal brain, and
the neocortices were mechanically triturated as described previously (Noh
and Gwag, 1997). Dissociated cells were plated on 6-well plates and 24-
well plates (approximately three cortices per plate) or on glass bottom 35-
mm dishes for ROS imaging. Plating media consist of Eagle’s minimal
essential medium (MEM, Earle’s salts, supplied glutamine-free) supple- BDNF induces neuronal death through NADPH oxidase | Kim et al. 829
mented with 5% horse serum, 5% FBS, 21 mM glucose, 26.5 mM bicar-
bonate, and 2 mM L-glutamine. For neuron–glia mixed cultures, 10  M cy-
tosine arabinoside (Ara C) was included to stop the overgrowth of
nonneuronal cells to cultures at days in vitro (DIV) 5–7 when glial cells
were confluent underneath neurons. After 2 d, cultures were then fed with
plating medium lacking fetal serum twice a week. Cultures were main-
tained at 37 C in a humidified 5% CO2 incubator. For neuron-rich cultures
( 95%), 2.5  M Ara C was included to cultures at 2–3 d in vitro (DIV 2–3)
as described previously (Gwag et al., 1997).
Induction and analysis of cell death
Mixed cortical cell cultures (DIV 12–14) were rinsed in serum-free MS
(MEM supplemented with 26.5 mM sodium bicarbonate and 21 mM glu-
cose) and then exposed to various concentrations of NGF, BDNF, or NT-3
in serum-free MS. Neuronal cell death was analyzed by measuring the
level of lactate dehydrogenase (LDH) released into the bathing medium.
The percentage of neuronal death was normalized to the mean LDH value
released after a sham control (defined as 0%) or continuous exposure to
500  M NMDA for 24 h (defined as 100%) The latter produces complete
neuronal death within 24 h. For experiments for serum deprivation, neu-
ron-rich cortical cell cultures (DIV 7) were placed into serum-free MS con-
taining 1  M MK-801 as described (Gwag et al., 1995). Neuronal death
was analyzed 24 and 48 h later by counting viable neurons excluding Try-
pan blue stained.
Transmission electron microscopic observation
Cultures were fixed in Karnovsky’s fixative solution (1% paraformaldehyde,
2% glutaraldehyde, 2 mM calcium chloride, 100 mM cacodylate buffer, pH
7.4) for 2 h, washed with cacodylate buffer, and postfixed in 1% osmium
tetroxide and 1.5% potassium ferrocyanide for 1 h. Cells were then stained
en bloc in 0.5% uranyl acetate, dehydrated through graded ethanol series,
and embedded in Poly/Bed 812 resin. Cells were sectioned using Reichert
Jung Ultracut S (Leica). After staining cells with uranyl acetate and lead ci-
trate, cells were observed and photographed under ZEISS EM 902A.
Intrastriatal injection of BDNF in rat brain
Adult male Sprague-Dawley rats weighing 250–300 g were anesthetized
intraperitoneally with chloral hydrate (400 mg/ml). Animals were placed in
a Kopf stereotaxic apparatus and injected with 1  g/ l of BDNF (dissolved
in 0.9% NaCl [saline]) or saline alone in the striatum at the following coor-
dinates: 1.0 mm rostral to bregma, 3.0 mm lateral to the midline, and 5.0
mm ventral from the dural surface. For each injection, a volume of 5  l
was delivered for 10 min via a 10- l Hamilton syringe. 3 min were al-
lowed before syringe withdrawal and wound closure. These rats were
killed 2 d later. Animals were anaesthetized and then perfused transcar-
dially with PBS followed by 3% paraformaldehyde. The brains were imme-
diately removed, postfixed, and then sectioned (8  m) on a microtome
(TPI, Inc.). Sections including the injection site were collected and stained
with hematoxylin and eosin. The lesion area was analyzed as described
previously (Won et al., 2000). Six serial sections including the needle track
and the largest injury area evident by decrease in staining intensity were
included for analysis of injury per each animal. The striatal section stained
with hematoxylin and eosin was scanned analyzed using a computer-
assisted image analysis system (SigmaScan, CA/TINA 2.0; KAIST).
ROS imaging
Cortical cell cultures (DIV 12–15) grown on glass bottom dishes were
loaded with 10  M dichlorodihydro fluorescein diacetate (DCDHF-DA) or
5   M hydroethidium (Molecular Probes) plus 2% Pluronic F-127 in
Hepes-buffered control salt solution (HCSS) buffer containing (in mM): 120
NaCl, 5 KCl, 1.6 MgCl2, 2.3 CaCl2, 15 glucose, 20 Hepes, and 10 NaOH.
Cultures were incubated for 20 min at 37 C and washed three times with
HCSS buffer. The fluorescence signal of oxidized DCDHF was observed at
room temperature on the stage of a Nikon Diaphot inverted microscope
equipped with a 100 W xenon lamp and filter (for oxidized DCDHF, exci-
tation   488 nm and emission   510 nm; for hydroethidine, excitation  
546 nm and emission   590 nm). The fluorescence images were analyzed
using a QuantiCell 700 system (Applied Imaging).
RNA preparation and cDNA microarray analysis
Total RNA was isolated from cortical cell cultures (DIV 12) by using RNA
zol B (Tel-Test Inc.). Approximately 1  g of total RNA was used to synthe-
size cDNA labeled with [ -
33p] dATP that was hybridized to rat gene filter
membranes (Research Genetics) at 42 C for 12–18 h. The membranes
were washed in 2  SSC buffer and 1% SDS at 50 C for 20 min, 0.5  SSC
and 1% SDS at room temperature for 15 min, and then wrapped up in
plastic wrap and apposed to a phosphorimager cassette. After exposure of
gene filters, the hybridization pattern was analyzed using Pathways™
4-universal microarray analysis software (Invitrogen).
RT-PCR
RT-PCR experiments were performed to confirm the target genes of BDNF
derived from cDNA expression microarray. Total RNA (1  g each) was in-
cubated in a reaction mixture containing dNTP (2.5 mM each), RNasin
(0.5 U), oligo dT primer (100 ng), and MMLV reverse transcriptase (200 U)
at 37 C for 1 h. The samples were incubated at 92 C for 10 min and trans-
ferred to 4 C. The reverse transcribed cDNA was subjected to PCR amplifi-
cation. PCR was performed according to manufacturer’s procedure (Takara
Shuzo Co.) sequentially (denaturation-annealing-extension) at the follow-
ing conditions: for p47-phox, 94 C for 30 S, 55 C for 30 S, and 72 C for 60
S (28 cycles); for p22-phox (homologous to cytochrome b558 in microarray)
and gp91-phox, 94 C for 45 S, 60 C for 60 S, and 72 C for 120 S (33 cy-
cles); and for GAPDH, 94 C for 35 S, 55 C for 45 S, and 72 C for 90 S (25
cycles). Primer sequences used were as follows (5 -3 ): for p22-phox,
GAATTCCGATGGGGCAGATCGAGTGGGCCA (forward) and GGATC-
CCGTCACACGACCTCATCTGTCACT (reverse); for p47-phox, CAGC-
CAGCACTATGTGTACA (forward) and GAACTCGTAGATCTCGGTGAA
(reverse); for gp91-phox, GAATTCCGATGGGGAACTGGGCTGTGAATG
(forward) and GGATCCCGTTAGAAGTTTTCCTTGTTGAAA (reverse); for
GAPDH, TCCATGACAACTTTGGCATCGTGG (forward) and GTTGCTGT-
TGAAGTCACAGGAGAC (reverse). PCR products were run on a 1.2% aga-
rose gel and visualized with ethidium bromide. The relative amount of
mRNA was measured using LAS-1000 systems (Fuji Photofilm Co.), nor-
malized to levels of GAPDH mRNA. DNA sequencing was performed with
Big Dye Terminator Chemistry from PerkinElmer on ABI PRISM
TM 377
DNA sequencer.
Western blot analysis
Cortical cell cultures were lysed in a lysis buffer containing 50 mM Tris-HCl
(pH 7.5), 1% Nonidet P-40, 150 mM NaCl, 0.5% deoxycholic acid, 0.1%
SDS, 1 mM PMSF, 10  g/ml pepstain A, and 100  g/ml leupeptin. Cell ly-
sates were centrifuged at 12,000 g for 10 min  25  g of protein was sub-
jected to electrophoresis on 12% SDS–polyacrylamide gel and transferred
to a nitrocellulose membrane. The blot was incubated in 2.5% BSA for 1 h,
incubated with goat polyclonal primary antibodies, anti–gp91-phox, anti–
p67-phox, or anti–p47-phox antibodies (1:1,000, Santa Cruz Biotechnol-
ogy, Inc.), and then reacted with a biotinylated anti–goat secondary anti-
body. Immunoreactivity was detected with Vectastain ABC kit (Vector
Laboratories) and luminol for ECL (Intron). The signal was analyzed by
quantitative densitometry using LAS-1000 systems (Fuji Photofilm Co.).
Subcellular fractionation
Cortical cell cultures were washed with ice-cold PBS and resuspended in
an isotonic buffer containing 10 mM Hepes, pH 8.0, 250 mM sucrose, 1
mM EDTA, 1 mM EGTA, 1 mM DTT, 2 mM PMSF, 100  g/ml leupeptin,
and 10  g/ml pepstatin A. For isolating the cytosol and membrane frac-
tion, the lysate was homogenized with a homogenizer (KONTE), centri-
fuged at 9,000 g for 10 min, and the supernatant was then centrifuged at
100,000 g for 1 h. The membrane fraction was obtained by resuspending
the pellet with 50  l lysis buffer, and the cytosolic fraction was obtained
from the supernatant.
Immunocytochemistry
Cortical cell cultures (DIV 12–14) grown on glass bottom dishes were fixed
in 4% paraformaldehyde for 30 min, incubated in 10% horse serum for 1 h,
and double immunolabeled with a mouse monoclonal antibody against
NeuN (1:400 dilution; Chemicon) and a goat polyclonal antibody against
p47-phox or p67-phox (1:200 dilution; Santa Cruz Biotechnology Inc.) for
2–4 h. Cultures were then reacted with fluorescein isothiocyanate-conju-
gated anti–goat IgG (1:200 dilution; Organon Teknika Corp.) and Texas
red–conjugated anti–mouse IgG (1:200; Vector Laboratories) for 1–2 h.
The fluorescence images were collected and analyzed with a fluorescence
microscopy (ZEISS) equipped with the Real-14
TM precision digital camera
(Apogee Instrument) and ImagePro Plus Plug-in.
Measurement of NADPH oxidase activity
Superoxide production was measured in a quantitative kinetic assay based
on the reduction of cytochrome c (Mayo and Curnutte, 1990). Cortical cell
cultures were suspended in PBS and incubated in a reaction mixture con-
taining 0.9 mM CaCl2, 0.5 mM MgCl2, and 7.5 mM glucose, 75  M cyto-
chrome c (Sigma-Aldrich), and 60  g/ml super oxide dismutase (Sigma-
Aldrich) for 3 min at 37 C. The superoxide production was determined by830 The Journal of Cell Biology | Volume 159, Number 5, 2002
measuring the absorbance of cytochrome c at 550 nm using a Thermomax
microplate reader and associated SOFTMAX Version 2.02 software (Mo-
lecular Devices Corp.).
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